Orphanet Journal of Rare Diseases | Cognitive and Intellectual Functioning in Leukodystrophy Patients: A Systematic Review

Recommend:

This study systematically reviewed cognitive and intellectual functioning in leukodystrophy patients, analyzed similarities and differences in cognitive domains across disease subtypes, and highlighted the impact of age on cognitive performance. By analyzing standardized neuropsychological test data, it revealed variations in intelligence and information processing speed across subtypes and provided critical directions for future research.

 

Literature Overview
This article, 'Cognitive and Intellectual Functioning in Leukodystrophy Patients: A Systematic Review', published in the Orphanet Journal of Rare Diseases, summarizes existing research on cognitive and intellectual functioning in leukodystrophies (such as CALD, MLD, AxD, and ALSP), aiming to determine whether these diseases have distinct cognitive and intellectual impairment profiles and whether differences exist across subtypes.

Background
Leukodystrophies are a group of inherited, progressive disorders affecting central nervous system white matter, often leading to neurological deterioration, including motor, cognitive, behavioral, and intellectual impairments. While these diseases are clinically characterized primarily by motor dysfunction and neurological degeneration, cognitive impairments are often overlooked, resulting in delayed interventions. This review highlights that although intelligence and information processing speed are the most commonly affected cognitive domains, the cognitive profiles of different subtypes remain unclear, and systematic assessment methods are lacking. Researchers aimed to evaluate the impact of these diseases on cognitive and intellectual functioning through a systematic literature review, laying the groundwork for developing standardized assessment guidelines and outcome measures for therapeutic trials.

 

A tool for comparing gene sequence differences across species or populations, suitable for evolutionary analysis.

Learn More

 

Research Methods and Design
The researchers systematically searched the MEDLINE, EMBASE, and PsychINFO databases for studies assessing cognitive functioning in leukodystrophy patients using standardized neuropsychological tests. A total of 13 group studies and 20 case studies were included, covering multiple cognitive domains including information processing speed, attention, memory, language, visuospatial functioning, and intelligence. Due to heterogeneity in testing methods and patient populations, the study used narrative data synthesis rather than meta-analysis to minimize bias.

Key Findings and Insights

• Information processing speed is the most frequently affected cognitive domain in leukodystrophies, particularly evident in childhood-onset subtypes
• Cognitive impairment profiles differ across subtypes; childhood-onset CALD, MLD, and AxD patients typically show earlier cognitive and intellectual decline compared to adult-onset cases
• Adult-onset CALD and ALSP patients often perform within normal ranges on information processing speed and attention/executive functioning, while childhood-onset patients show significant deficits
• Some leukodystrophy patients exhibit marked intellectual impairments even in early disease stages, highlighting the need for early screening and intervention
• Cognitive function in asymptomatic individuals is typically preserved, suggesting that cognitive assessments should be stage-dependent
• The study emphasizes the importance of developing standardized cognitive assessment tools and specific outcome measures to support therapeutic trials

Implications and Future Directions
This review reveals the widespread nature of cognitive and intellectual impairments in leukodystrophy patients, especially those with childhood-onset forms. Researchers note that the lack of systematic and standardized assessment tools has led to underestimation of cognitive impairments. Future research should focus on establishing a unified neuropsychological assessment framework, defining cognitive trajectories across disease stages for each subtype, and exploring early intervention strategies to delay cognitive decline. These findings also suggest potential neuropsychological endpoints for therapeutic trials, which may improve the sensitivity and effectiveness of clinical studies.

 

A tool for assessing the pathogenic potential of genetic variants, providing reference for functional analysis.

Learn More

 

Conclusion
This systematic review comprehensively assessed changes in cognitive and intellectual functioning among leukodystrophy patients, emphasizing the significant impact of age at onset. Childhood-onset patients typically exhibit earlier and more severe cognitive and intellectual impairments, while adult-onset patients demonstrate relatively stable cognitive function in early stages. Information processing speed is a commonly impaired domain across multiple subtypes, highlighting its importance in early assessments. Although some studies have explored cognitive functioning in leukodystrophies, systematic and standardized tools remain scarce, limiting clinical interventions and therapeutic trial design. Future research should prioritize high-quality, longitudinal studies to define cognitive profiles of each subtype and establish unified assessment criteria. These findings provide a foundation for developing clinical assessment guidelines and neuropsychological endpoints for therapeutic trials.

 

Wietske H M Grol, Marjo S van der Knaap, Nicole I Wolf, and Gert J Geurtsen. Cognitive and intellectual functioning in leukodystrophy patients: a systematic review. Orphanet Journal of Rare Diseases.